{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:45:57Z","timestamp":1792590357976,"version":"4.5.0"},"reference-count":44,"publisher":"MyJove Corporation","issue":"229","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70123","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:02:15Z","timestamp":1772841735000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Lithium Carbonate Combined with Olanzapine, Risperidone, or Quetiapine in Bipolar Disorder Treatment and Effects on Glycolipid Metabolism"],"prefix":"10.3791","author":[{"given":"Dongli","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaguo","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41398-024-02886-z","type":"journal-article","article-title":"Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents","volume":"14","author":"Yin","year":"2024","unstructured":"Yin, B. et al. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents. Transl Psychiatry., 14 (1), 163 (2024).","journal-title":"Transl Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"105553","DOI":"10.1016\/j.jff.2023.105553","type":"journal-article","article-title":"Adjunct therapy with probiotics for depressive episodes of bipolar disorder type \u2160: A randomized placebo-controlled trial","volume":"105","author":"Zhang","year":"2023","unstructured":"Zhang, J. et al. Adjunct therapy with probiotics for depressive episodes of bipolar disorder type \u2160: A randomized placebo-controlled trial. J Funct Foods., 105, 105553 (2023).","journal-title":"J Funct Foods"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12888-024-05682-7","type":"journal-article","article-title":"Association of major depression, schizophrenia, and bipolar disorder with thyroid cancer: a bidirectional two-sample Mendelian randomized study","volume":"24","author":"Qiu","year":"2024","unstructured":"Qiu, R. et al. Association of major depression, schizophrenia, and bipolar disorder with thyroid cancer: a bidirectional two-sample Mendelian randomized study. BMC Psychiatry., 24 (1), 261 (2024).","journal-title":"BMC Psychiatry"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/14737175.2024.2355264","type":"journal-article","article-title":"Bipolar disorder staging and the impact it has on its management: an update","volume":"24","author":"Dell'Osso","year":"2024","unstructured":"Dell'Osso, B., Cremaschi, L., Macellaro, M, Cafaro, R., Girone, N. Bipolar disorder staging and the impact it has on its management: an update. Expert Rev Neurother., 24 (6), 565-574 (2024).","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"ref5","first-page":"218","type":"journal-article","article-title":"Neuropsychological aspects of bipolar disorder","volume":"51","author":"Baena Oquendo","year":"2022","unstructured":"Baena Oquendo, S., Garc\u00eda Valencia, J., Vargas, C., L\u00f3pez Jaramillo, C. Neuropsychological aspects of bipolar disorder. Rev Colomb Psiquiatr (Engl Ed)., 51 (3), 218-226 (2022).","journal-title":"Rev Colomb Psiquiatr (Engl Ed)"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/ph17091223","type":"journal-article","article-title":"What patients with bipolar disorder need to know about lithium","volume":"17","author":"Post","year":"2024","unstructured":"Post, R. M., Rybakowski, J. K. What patients with bipolar disorder need to know about lithium. Pharmaceuticals (Basel). 17 (9), 1223 (2024).","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.euroneuro.2024.03.010","type":"journal-article","article-title":"Lithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging","volume":"85","author":"Zafrilla L\u00f3pez","year":"2024","unstructured":"Zafrilla L\u00f3pez. et al. Lithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging. Eur Neuropsychopharmacol., 85, 23-31 (2024).","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref8","first-page":"102581","type":"journal-article","article-title":"Effect of antipsychotics and mood stabilisers on metabolism in disorder: a network meta-analysis of randomised-controlled trials","volume":"71","author":"Kong","year":"2024","unstructured":"Kong, L. et al. Effect of antipsychotics and mood stabilisers on metabolism in bipolar disorder: a network meta-analysis of randomised-controlled trials. E Clinical Medicine., 71, 102581 (2024).","journal-title":"E Clinical Medicine"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaac.2024.07.920","type":"journal-article","article-title":"Systematic review and network meta-analysis: efficacy and safety of antipsychotics vs antiepileptics or lithium for acute mania in children and adolescents","volume":"64","author":"Vita","year":"2025","unstructured":"Vita, G. et al. Systematic review and network meta-analysis: efficacy and safety of antipsychotics vs antiepileptics or lithium for acute mania in children and adolescents. J Am Acad Child Adolesc Psychiatry., 64 (2), 143-157 (2025).","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"e2458608","DOI":"10.1001\/jamanetworkopen.2024.58608","type":"journal-article","article-title":"Lithium for bipolar disorder and risk of thyroid dysfunction and chronic kidney disease","volume":"8","author":"Chan","year":"2025","unstructured":"Chan, J. K. N., et al. Lithium for bipolar disorder and risk of thyroid dysfunction and chronic kidney disease. JAMA Netw. 8 (2), e2458608 (2025).","journal-title":"JAMA Netw"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/02698811211029738","type":"journal-article","article-title":"Effects on suicidal risk: Comparison of clozapine to other newer medicines indicated to treat schizophrenia or bipolar disorder","volume":"35","author":"Forte","year":"2021","unstructured":"Forte, A. et al. Effects on suicidal risk: Comparison of clozapine to other newer medicines indicated to treat schizophrenia or bipolar disorder. J Psychopharmacol., 35 (9), 1074-1080 (2021).","journal-title":"J Psychopharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jad.2017.02.012","type":"journal-article","article-title":"Maintenance therapy with second generation antipsychotics for bipolar disorder\u2013 a systematic review and meta-analysis","volume":"213","author":"Lindstr\u00f6m","year":"2017","unstructured":"Lindstr\u00f6m, L., Lindstr\u00f6m, E., Nilsson, M., H\u00f6istad, M. Maintenance therapy with second generation antipsychotics for bipolar disorder\u2013 a systematic review and meta-analysis. J. Affect. Disord. 213, 138\u2013150 (2017).","journal-title":"J. Affect. Disord"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"105973","DOI":"10.1016\/j.jddst.2024.105973","type":"journal-article","article-title":"Reservoir-type intranasal implants for sustained release of risperidone: A potential alternative for long-term treatment of schizophrenia","volume":"99","author":"Utomo","year":"2024","unstructured":"Utomo, E. et al. Reservoir-type intranasal implants for sustained release of risperidone: A potential alternative for long-term treatment of schizophrenia. J Drug Deliv Sci Tec., 99, 105973 (2024).","journal-title":"J Drug Deliv Sci Tec"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10072-021-05348-2","type":"journal-article","article-title":"Bipolar disorder and the risk for stroke incidence and mortality: a meta-analysis","volume":"43","author":"Yuan","year":"2022","unstructured":"Yuan, M. et al. Bipolar disorder and the risk for stroke incidence and mortality: a meta-analysis. Neurol Sci., 43 (1), 467-476 (2022).","journal-title":"Neurol Sci"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/acps.13715","type":"journal-article","article-title":"Cardiovascular mortality in bipolar disorder: Population-based cohort study","volume":"150","author":"Palj\u00e4rvi","year":"2024","unstructured":"Palj\u00e4rvi, T. et al. Cardiovascular mortality in bipolar disorder: Population-based cohort study. Acta Psychiat Scand., 150 (2), 56-64 (2024).","journal-title":"Acta Psychiat Scand"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jad.2022.09.048","type":"journal-article","article-title":"Sex-specific associations between lifetime diagnosis of bipolar disorder and cardiovascular disease: A cross-sectional analysis of 257,673 participants from the UK Biobank","volume":"319","author":"Ortiz","year":"2022","unstructured":"Ortiz, A. et al. Sex-specific associations between lifetime diagnosis of bipolar disorder and cardiovascular disease: A cross-sectional analysis of 257,673 participants from the UK Biobank. J Affec Disorders., 319, 663-669 (2022).","journal-title":"J Affec Disorders"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/15622975.2018.1500033","type":"journal-article","article-title":"Adiponectin is decreased in bipolar depression","volume":"20","author":"Platzer","year":"2019","unstructured":"Platzer, M. et al. Adiponectin is decreased in bipolar depression. World J. Biol. Psychiatry., 20 (10), 813-820 (2019).","journal-title":"World J. Biol. Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jad.2020.03.103","type":"journal-article","article-title":"Accuracy of diagnostic judgments using ICD-11 vs. ICD-10 diagnostic guidelines for obsessive-compulsive and related disorders","volume":"273","author":"Kogan","year":"2020","unstructured":"Kogan, C. S., et al. Accuracy of diagnostic judgments using ICD-11 vs. ICD-10 diagnostic guidelines for obsessive-compulsive and related disorders. J. Affect. Disord. 273, 328\u2013340 (2020).","journal-title":"J. Affect. Disord"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"111042","DOI":"10.1016\/j.jpsychores.2022.111042","type":"journal-article","article-title":"The differences in serum C1q levels between first-episode patients with bipolar disorder and major depressive disorder","volume":"162","author":"Chen","year":"2022","unstructured":"Chen, Q., Sun, T., Li, D., Zhao, Z., Li, Y. The differences in serum C1q levels between first-episode patients with bipolar disorder and major depressive disorder. J. Psychosom. Res. 162, 111042 (2022).","journal-title":"J. Psychosom. Res"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1080\/03007995.2023.2260302","type":"journal-article","article-title":"Neutrophil\/high-density lipoprotein cholesterol (HDL), monocyte\/HDL and platelet\/HDL ratios are increased in acute mania as markers of inflammation, even after controlling for confounding factors","volume":"39","author":"Korkmaz","year":"2023","unstructured":"Korkmaz, \u015e. A., K\u0131zg\u0131n, S. Neutrophil\/high-density lipoprotein cholesterol (HDL), monocyte\/HDL and platelet\/HDL ratios are increased in acute mania as markers of inflammation, even after controlling for confounding factors. Curr. Med. Res. Opin. 39 (10), 1383\u20131390 (2023).","journal-title":"Curr. Med. Res. Opin"},{"issue":"11","key":"ref21","first-page":"12843","type":"journal-article","article-title":"Clinical efficacy of thoracoscopic surgery by subxiphoid approach for thymoma and its influence on intraoperative blood loss and postoperative complications","volume":"13","author":"Shen","year":"2021","unstructured":"Shen, P., et al. Clinical efficacy of thoracoscopic surgery by subxiphoid approach for thymoma and its influence on intraoperative blood loss and postoperative complications. Am. J. Transl. Res. 13 (11), 12843 (2021).","journal-title":"Am. J. Transl. Res"},{"issue":"10265","key":"ref22","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","type":"journal-article","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","unstructured":"McIntyre, R. S., et al. Bipolar disorders. Lancet., 396 (10265), 1841\u20131856 (2020).","journal-title":"Lancet"},{"key":"ref23","type":"book","article-title":"Bipolar disorder","volume-title":"N. Engl. J. Med","author":"Carvalho","year":"2020","unstructured":"Carvalho, A. F., Firth, J., Vieta, E. Bipolar disorder. N. Engl. J. Med. 383 (1), 58\u201366 (2020)."},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1038\/s41380-020-00946-6","type":"journal-article","article-title":"Mood stabilizers and\/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials","volume":"26","author":"Kishi","year":"2021","unstructured":"Kishi, T., et al. Mood stabilizers and\/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials. Mol. Psychiatry. 26 (8), 4146\u20134157 (2021).","journal-title":"Mol. Psychiatry"},{"issue":"14","key":"ref25","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jama.2023.18588","type":"journal-article","article-title":"Diagnosis and treatment of bipolar disorder: a review","volume":"330","author":"Nierenberg","year":"2023","unstructured":"Nierenberg, A. A., et al. Diagnosis and treatment of bipolar disorder: a review. JAMA. 330 (14), 1370\u20131380 (2023).","journal-title":"JAMA"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4067\/s0034-98872024000400498","type":"journal-article","article-title":"Endocrinological effects of lithium: pathophysiological mechanisms and clinical implications","volume":"152","author":"Manr\u00edquez","year":"2024","unstructured":"Manr\u00edquez, F., Mosso, L., Fardella, C. Endocrinological effects of lithium: pathophysiological mechanisms and clinical implications. Rev. Med. Chil. 152 (4), 498\u2013507 (2024).","journal-title":"Rev. Med. Chil"},{"issue":"2","key":"ref27","first-page":"23cr03666","type":"journal-article","article-title":"Treating schizophrenia and bipolar I disorder in the real-world setting: effectiveness and safety of olanzapine\/samidorphan combination","volume":"26","author":"Price","year":"2024","unstructured":"Price, M. Z., Price, R. L. Treating schizophrenia and bipolar I disorder in the real-world setting: effectiveness and safety of olanzapine\/samidorphan combination. Prim. Care Companion CNS Disord. 26 (2), 23cr03666 (2024).","journal-title":"Prim. Care Companion CNS Disord"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14737175.2024.2370349","type":"journal-article","article-title":"An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder","volume":"24","author":"Faden","year":"2024","unstructured":"Faden, J., Ramirez, C., Martinez, V., Citrome, L. An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder. Expert Rev. Neurother. 24 (8), 761\u2013771 (2024).","journal-title":"Expert Rev. Neurother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1497119","DOI":"10.3389\/fpsyt.2024.1497119","type":"journal-article","article-title":"Model-informed precision dosing of quetiapine in bipolar affective disorder patients: initial dose recommendation","volume":"15","author":"Zheng","year":"2024","unstructured":"Zheng, Z. Q., et al. Model-informed precision dosing of quetiapine in bipolar affective disorder patients: initial dose recommendation. Front. Psychiatry. 15, 1497119 (2024).","journal-title":"Front. Psychiatry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jad.2021.10.100","type":"journal-article","article-title":"Association between abnormal glycolipid level and cognitive dysfunction in drug-na\u00efve patients with bipolar disorder","volume":"297","author":"Qiu","year":"2022","unstructured":"Qiu, Y., et al. Association between abnormal glycolipid level and cognitive dysfunction in drug-na\u00efve patients with bipolar disorder. J. Affect. Disord. 297, 477\u2013485 (2022).","journal-title":"J. Affect. Disord"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2006-951386","type":"journal-article","article-title":"Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium","volume":"39","author":"Yoshimura","year":"2006","unstructured":"Yoshimura, R., Ueda, N., Shinkai, K., Nakamura, J. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium. Pharmacopsychiatry., 39 (6), 233\u2013234 (2006).","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/ph16040603","type":"journal-article","article-title":"Receptors involved in mental disorders and the use of clozapine, chlorpromazine, olanzapine, and aripiprazole to treat mental disorders","volume":"16","author":"Mlambo","year":"2023","unstructured":"Mlambo, R., Liu, J., Wang, Q., Tan, S., Chen, C. Receptors involved in mental disorders and the use of clozapine, chlorpromazine, olanzapine, and aripiprazole to treat mental disorders. Pharmaceuticals. 16 (4), 603 (2023).","journal-title":"Pharmaceuticals"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/biomedicines12071403","type":"journal-article","article-title":"Olanzapine modulate lipid metabolism and adipose tissue accumulation via hepatic muscarinic M3 receptor-mediated Alk-related signaling","volume":"12","author":"Su","year":"2024","unstructured":"Su, Y., et al. Olanzapine modulate lipid metabolism and adipose tissue accumulation via hepatic muscarinic M3 receptor-mediated Alk-related signaling. Biomedicines. 12 (7), 1403 (2024).","journal-title":"Biomedicines"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1201\/9780429242717-15","type":"book","article-title":"Antipsychotic drugs","volume-title":"Advances in Neuropharmacology","author":"Kaur","year":"2020","unstructured":"Kaur, H., et al. Antipsychotic drugs. In: Advances in Neuropharmacology. Apple Academic Press., 297\u2013316 (2020)."},{"key":"ref35","first-page":"162","type":"journal-article","article-title":"Dopamine D2\/3 receptors in Parkinson's disease patients. NeuroImage Clinical","volume":"29","author":"Deutschlander","year":"2019","unstructured":"Deutschlander, A. et al. Dopamine D2\/3 receptors in Parkinson's disease patients. NeuroImage Clinical, 12, 41\u201346. Trans Med CNS Drug Dev., 29, 162 (2019).","journal-title":"Trans Med CNS Drug Dev"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12888-023-05488-z","type":"journal-article","article-title":"Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients","volume":"24","author":"Wang","year":"2024","unstructured":"Wang, X. Y., et al. Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients. BMC Psychiatry. 24 (1), 41 (2024).","journal-title":"BMC Psychiatry"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"e13347","DOI":"10.1111\/jne.13347","type":"journal-article","article-title":"Metabolic effects of atypical antipsychotics: molecular targets","volume":"35","author":"Fonseca","year":"2023","unstructured":"Fonseca, M., Carmo, F., Martel, F. Metabolic effects of atypical antipsychotics: molecular targets. J. Neuroendocrinol. 35 (12), e13347 (2023).","journal-title":"J. Neuroendocrinol"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/ph14030238","type":"journal-article","article-title":"Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences","volume":"14","author":"Carli","year":"2021","unstructured":"Carli, M., et al. Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences. Pharmaceuticals., 14 (3), 238 (2021).","journal-title":"Pharmaceuticals"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11920-020-1130-0","type":"journal-article","article-title":"Bipolar disorder and suicide: a review","volume":"22","author":"Miller","year":"2020","unstructured":"Miller, J. N., Black, D. W. Bipolar disorder and suicide: a review. Curr. Psychiatry Rep. 22 (2), 6 (2020).","journal-title":"Curr. Psychiatry Rep"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2174\/1570159X21666230224102318","type":"journal-article","article-title":"Pharmacological strategies for bipolar disorders in acute phases and chronic management with a special focus on lithium, valproic acid, and atypical","volume":"21","author":"Carli","year":"2023","unstructured":"Carli, M., et al. Pharmacological strategies for bipolar disorders in acute phases and chronic management with a special focus on lithium, valproic acid, and atypical antipsychotics. Curr. Neuropharmacol. 21 (4), 935\u2013950 (2023).","journal-title":"Curr. Neuropharmacol"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/acps.13762","type":"journal-article","article-title":"Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: a nationwide cohort study on relapse risk and treatment safety","volume":"151","author":"Lintunen","year":"2025","unstructured":"Lintunen, J., et al. Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: a nationwide cohort study on relapse risk and treatment safety. Acta Psychiatr. Scand. 151 (1), 81\u201391 (2025).","journal-title":"Acta Psychiatr. Scand"},{"issue":"12","key":"ref42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/2045125318804364","type":"journal-article","article-title":"Medication nonadherence in bipolar disorder: a narrative review","volume":"8","author":"Jawad","year":"2018","unstructured":"Jawad, I., Watson, S., Haddad, P. M., Talbot, P. S., McAllister-Williams, R. H. Medication nonadherence in bipolar disorder: a narrative review. Ther. Adv. Psychopharmacol. 8 (12), 349\u2013363 (2018).","journal-title":"Ther. Adv. Psychopharmacol"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12888-020-02597-x","type":"journal-article","article-title":"Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report","volume":"20","author":"Szota","year":"2020","unstructured":"Szota, A. M., Radajewska, I., Grudzka, P., Araszkiewicz, A. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report. BMC Psychiatry., 20 (1), 179 (2020).","journal-title":"BMC Psychiatry"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/brainsci13030414","type":"journal-article","article-title":"Application of antipsychotic drugs in mood disorders","volume":"13","author":"Rybakowski","year":"2023","unstructured":"Rybakowski, J. K. Application of antipsychotic drugs in mood disorders. Brain Sci. 13 (3), 414 (2023).","journal-title":"Brain Sci"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/70123\/efficacy-lithium-carbonate-combined-with-olanzapine-risperidone-or","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:18:14Z","timestamp":1792588694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70123\/efficacy-lithium-carbonate-combined-with-olanzapine-risperidone-or"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":44,"journal-issue":{"issue":"229","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70123","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]}}}